Date: Sunday, October 21, 2018
Session Title: Health Services Research Poster I – ACR/ARHP
Session Type: ACR/ARHP Combined Abstract Session
Session Time: 9:00AM-11:00AM
Disclosure: J. H. Best, Genentech, Inc., 3; P. Juneau, Truven Health Analytics, an IBM Coompany, 3; A. Kong, Truven Health Analytics, an IBM Company, 3.
To cite this abstract in AMA style:Best JH, Juneau P, Kong A. Comparison of Real-World Costs between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparison-of-real-world-costs-between-patients-with-rheumatoid-arthritis-treated-with-subcutaneously-administered-biologics-previously-treated-with-another-biologic/. Accessed May 29, 2023.
« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-real-world-costs-between-patients-with-rheumatoid-arthritis-treated-with-subcutaneously-administered-biologics-previously-treated-with-another-biologic/